South Korea Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

South Korean diabetes drugs and devices market is segmented by drugs (insulin, oral anti-diabetic drugs, non-insulin injectable drugs, and combination drugs) and devices (management devices such as insulin pumps, insulin pens, syringes, cartridges, and jet injectors, and monitoring devices including self-monitoring blood and continuous glucose monitoring). The report offers the value (in USD) and volume (in unit) for the above segments.

South Korea Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

South Korea Diabetes Drugs and Devices Market Size

South Korea Diabetes Drugs and Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 3.40 %

Major Players

South Korea Diabetes Drugs and Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of South Korea Diabetes Drugs and Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

South Korea Diabetes Drugs and Devices Market Analysis

The South Korea Diabetes Drugs and Devices Market is expected to register a CAGR of greater than 3.4% during the forecast period.

The COVID-19 pandemic has significantly impacted the diabetes care device market. The prevalence of diabetes in patients hospitalized with COVID-19 and evidence that improved glycemic control may improve outcomes and shorten hospital stays in patients with SARS-CoV-2 has led to a reduction in diabetes mellitus. The importance of therapeutic equipment is emphasized. The pandemic has also highlighted opportunities to continue and expand innovation in diabetes care through virtual consultations between healthcare providers and people with diabetes and the use of diabetes technology. Crisis management has led to unprecedented interest in telemedicine from patients and providers, removing many long-standing regulatory barriers. The prevalence of adult diabetes is high in South Korea, and the economic burden of diabetes is greater than that of cancer. Complications of diabetes and associated comorbidities and hospitalizations are associated with the high cost of diabetes, a cost factor. Treating patients with diabetic complications requires effective strategies to reduce the use of medical resources and the financial burden. Increased information on the extent and specific factors of the economic burden of diabetes in South Korea is expected to encourage health policymakers to prioritize prevention and treatment and allocate more healthcare resources to diabetes.

Diabetes is associated with many health complications. A diabetic need to monitor his blood sugar and make corrections many times throughout the day to maintain his nominal blood sugar, such as administering additional insulin or consuming other carbohydrates. Diabetes is a growing health burden nationwide and is a leading cause of premature death, morbidity, and loss of economic growth.

Thus, the above factors are expected to drive market growth over the forecast period.

South Korea Diabetes Drugs and Devices Industry Overview

Manufacturers have always innovated to survive in the industry. Big industries, as an example, Abbott and Medtronic, have made abundant mergers, acquisitions, and partnerships to secure industry dominance while adhering to biological development techniques. The manufacturers of insulin delivery equipment are spending substantial amounts on the R&D of the gadgets. For example, Novo Nordisk partnered with Abbott Diabetes Care, which may also aid in enabling insulin data to be shared between Novo Nordisk-connected insulin pens and digital health trappings well qualified to the FreeStyle Libre portfolio of cosmetics.

South Korea Diabetes Drugs and Devices Market Leaders

  1. Medtronics

  2. Roche

  3. NovoNordisk

  4. Sanofi

  5. Omnipod

  6. *Disclaimer: Major Players sorted in no particular order
South Korea Diabetes Drugs And Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

South Korea Diabetes Drugs and Devices Market News

  • January 2023: Adela (Online Selling website for Abbott FreeStyle Libre in Korea) announced that the freestyle Libre selling price is expected to be raised by 10% in Korea due to a continuous rise in raw materials and inflation.
  • November 2022: AstraZeneca announced new findings from a pre-specified analysis of DELIVER Phase III trial data showing that Farxiga (dapagliflozin) improved symptom burden and health-related quality of life in patients with heart failure and mildly reduced or preserved ejection fraction compared with placebo.

Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Restraints
  • 4.3 Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products and Services
    • 4.3.5 Intensity of Competitive Rivalry

5. Market Segmentation (Market Size by Value - USD)

  • 5.1 Devices
    • 5.1.1 Monitoring Devices
    • 5.1.1.1 Self-monitoring Blood Glucose Devices
    • 5.1.1.2 Continuous Blood Glucose Monitoring
    • 5.1.2 Management Devices
    • 5.1.2.1 Insulin Pump
    • 5.1.2.2 Insulin Syringes
    • 5.1.2.3 Insulin Cartridges
    • 5.1.2.4 Disposable Pens
  • 5.2 Drugs
    • 5.2.1 Oral Anti-Diabetes Drugs
    • 5.2.2 Insulin Drugs
    • 5.2.3 Combination Drugs
    • 5.2.4 Non-Insulin Injectable Drugs

6. Market Indicators

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Novo Nordisk
    • 7.1.2 Medtronic
    • 7.1.3 Insulet
    • 7.1.4 Tandem
    • 7.1.5 Ypsomed
    • 7.1.6 Novartis
    • 7.1.7 Sanofi
    • 7.1.8 Eli Lilly
    • 7.1.9 Abbottt
    • 7.1.10 Roche
    • 7.1.11 Astrazeneca
    • 7.1.12 Dexcom
    • 7.1.13 Pfizer
  • *List Not Exhaustive
  • 7.2 Company Share Analysis

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

South Korea Diabetes Drugs and Devices Industry Segmentation

Oral diabetes medications (taken by mouth) help administer blood glucose levels in individuals who have diabetes but still produce several insulin, largely individuals with Type 2 diabetes and prediabetes. The South Korea diabetes drugs and devices market is segmented by drugs (insulin, oral anti-diabetic drugs, non-insulin injectable drugs, and combination drugs), and devices (management devices such as insulin pumps, insulin pens, syringes, cartridges, and jet injectors, and monitoring devices including self-monitoring blood and continuous glucose monitoring). The report offers the value (in USD) and volume (in unit) for the above segments.

Devices Monitoring Devices Self-monitoring Blood Glucose Devices
Continuous Blood Glucose Monitoring
Management Devices Insulin Pump
Insulin Syringes
Insulin Cartridges
Disposable Pens
Drugs Oral Anti-Diabetes Drugs
Insulin Drugs
Combination Drugs
Non-Insulin Injectable Drugs
Need A Different Region or Segment?
Customize Now

Frequently Asked Questions

What is the current undefined size?

The undefined is projected to register a CAGR of greater than 3.4% during the forecast period (2025-2030)

Who are the key players in undefined?

Medtronics, Roche, NovoNordisk, Sanofi and Omnipod are the major companies operating in the undefined.

What years does this undefined cover?

The report covers the undefined historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the undefined size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

South Korea Diabetes Drugs and Devices Industry Report

Statistics for the 2025 South Korea Diabetes Drugs and Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. South Korea Diabetes Drugs and Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.